申请人:Takeda Chemical Industries, Ltd.
公开号:US04603135A1
公开(公告)日:1986-07-29
Dihydropyridine derivatives and acid addition salts thereof which are of use as prophylactic or/and therapeutic drugs for cardiovascular diseases, said dihydropyridine derivatives having the formula ##STR1## wherein R.sup.1 is a hydrogen atom or an aryl, R.sup.2 and R.sup.3 are the same or different and each is an aryl, R.sup.4 and R.sup.6 are the same or different and each is a lower alkyl, R.sup.5 is amino or a lower alkyl, A is an alkylene, X is N or CH and m and n are the same or different and each is 0 or 1, with the proviso that when X is N, R.sup.5 is amino.
二氢吡啶衍生物及其酸盐是用作心血管疾病的预防或治疗药物,所述二氢吡啶衍生物具有以下结构式:其中R.sup.1是氢原子或芳基,R.sup.2和R.sup.3相同或不同,每个都是芳基,R.sup.4和R.sup.6相同或不同,每个是较低烷基,R.sup.5是氨基或较低烷基,A是烷基,X是N或CH,m和n相同或不同,每个为0或1,但当X为N时,R.sup.5为氨基。